
Investing.com – Israel stocks were lower after the close on Wednesday, as losses in the Banking, Financials and Insurance sectors led shares lower.
At the close in Tel Aviv, the TA 35 declined 0.98%.
The best performers of the session on the TA 35 were Teva Pharmaceutical Industries Ltd (TASE:TEVA), which rose 3.84% or 118.00 points to trade at 3,190.00 at the close. Meanwhile, Strauss Group (TASE:STRS) added 2.99% or 258.00 points to end at 8,888.00 and Bezeq Israeli Telecommunication Corp Ltd (TASE:BEZQ) was up 1.41% or 8.40 points to 605.20 in late trade.
The worst performers of the session were ICL Israel Chemicals Ltd (TASE:ICL), which fell 3.26% or 90.00 points to trade at 2,669.00 at the close. Shikun&Binui (TASE:SKBN) declined 3.16% or 37.00 points to end at 1,134.00 and Phoenix Holdings Ltd (TASE:PHOE1) was down 3.15% or 121.00 points to 3,722.00.
Falling stocks outnumbered advancing ones on the Tel Aviv Stock Exchange by 328 to 163 and 25 ended unchanged.
Shares in ICL Israel Chemicals Ltd (TASE:ICL) fell to 52-week lows; losing 3.26% or 90.00 to 2,669.00. Shares in Shikun&Binui (TASE:SKBN) fell to 52-week lows; falling 3.16% or 37.00 to 1,134.00.
Crude oil for January delivery was up 2.88% or 2.17 to $77.56 a barrel. Elsewhere in commodities trading, Brent oil for delivery in February rose 2.63% or 2.12 to hit $82.80 a barrel, while the February Gold Futures contract fell 0.29% or 5.30 to trade at $1,820.20 a troy ounce.
USD/ILS was down 0.19% to 3.40, while EUR/ILS unchanged 0.09% to 3.62.
The US Dollar Index Futures was down 0.21% at 103.35.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.